Detailansicht

Hering, A., Emidio, N. B., & Muttenthaler, M. (2022). Expanding the versatility and scope of the oxime ligation: rapid bioconjugation to disulfide-rich peptides. Chemical Communications, 58(65), 9100-9103. https://doi.org/10.1039/d2cc03752a

Liu, H., & Muttenthaler, M. (2022). High Oxytocin Receptor Expression Linked to Increased Cell Migration and Reduced Survival in Patients with Triple-Negative Breast Cancer. Biomedicines, 10(7), [1595]. https://doi.org/10.3390/biomedicines10071595

Hering, A., Jieu, B., Jones, A., & Muttenthaler, M. (2022). Approaches to Improve the Quantitation of Oxytocin in Human Serum by Mass Spectrometry. Frontiers in Chemistry, 10, [889154]. https://doi.org/10.3389/fchem.2022.889154

Kremsmayr, T., Aljnabi, A., Blanco-Canosa, J. B., Tran, H. N. T., Emidio, N. B., & Muttenthaler, M. (2022). On the Utility of Chemical Strategies to Improve Peptide Gut Stability. Journal of Medicinal Chemistry, 65(8), 6191-6206. https://doi.org/10.1021/acs.jmedchem.2c00094

Baumgartner, M., Lang, M., Holley, H., Crepaz, D., Hausmann, B., Pjevac, P., Moser, D., Haller, F., Hof, F., Beer, A., Orgler, E., Frick, A., Khare, V., Evstatiev, R., Strohmaier, S., Primas, C., Dolak, W., Köcher, T., Klavins, K., ... Gasche, C. (2021). Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis. Gastroenterology, 161(4), 1245-1256. https://doi.org/10.1053/j.gastro.2021.06.024

Emidio, N. B., Meli, R., Tran, H. N. T., Baik, H., Morisset-Lopez, S., Elliott, A. G., Blaskovich, M. A. T., Spiller, S., Beck-Sickinger, A. G., Schroeder, C. I., & Muttenthaler, M. (2021). Chemical Synthesis of TFF3 Reveals Novel Mechanistic Insights and a Gut-Stable Metabolite. Journal of Medicinal Chemistry, 64(13), 9484-9495. https://doi.org/10.1021/acs.jmedchem.1c00767

Emidio, N. B., Tran, H. N. T., Andersson, A., Dawson, P. E., Albericio, F., Vetter, I., & Muttenthaler, M. (2021). Improving the Gastrointestinal Stability of Linaclotide. Journal of Medicinal Chemistry, 64(12), 8384-8390. https://doi.org/10.1021/acs.jmedchem.1c00380

Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021). Trends in peptide drug discovery. Nature Reviews Drug Discovery, 20(4), 309-325. https://doi.org/10.1038/s41573-020-00135-8

Dekan, Z., Kremsmayr, T., Keov, P., Godin, M., Teakle, N., Durrauer, L., Xiang, H., Gharib, D., Bergmayr, C., Hellinger, R., Gay, M., Vilaseca, M., Kurzbach, D., Albericio, F., Alewood, P. F., Gruber, C. W., & Muttenthaler, M. (2021). Nature-inspired dimerization as a strategy to modulate neuropeptide pharmacology exemplified with vasopressin and oxytocin. Chemical Science, 12(11), 4057-4062. https://doi.org/10.1039/d0sc05501h

Che, K., Muttenthaler, M., & Kurzbach, D. (2021). Conformational selection of vasopressin upon V_1a receptor binding. Computational and Structural Biotechnology Journal, 19, 5826-5833. https://doi.org/10.1016/j.csbj.2021.10.024

Peschel, A., Cardoso, F. C., Walker, A. A., Durek, T., Stone, M. R. L., Emidio, N. B., Dawson, P. E., Muttenthaler, M., & King, G. F. (2020). Two for the Price of One: Heterobivalent Ligand Design Targeting Two Binding Sites on Voltage-Gated Sodium Channels Slows Ligand Dissociation and Enhances Potency. Journal of Medicinal Chemistry, 63(21), 12773-12785. https://doi.org/10.1021/acs.jmedchem.0c01107

Mendel, H. C., Kaas, Q., & Muttenthaler, M. (2020). Neuropeptide signalling systems - An underexplored target for venom drug discovery. Biochemical Pharmacology, 181, [114129]. https://doi.org/10.1016/j.bcp.2020.114129

Touchard, A., Mendel, H. C., Boulogne, I., Herzig, V., Braga Emidio, N., King, G. F., Triquigneaux, M., Jaquillard, L., Beroud, R., De Waard, M., Delalande, O., Dejean, A., Muttenthaler, M., & Duplais, C. (2020). Heterodimeric Insecticidal Peptide Provides New Insights into the Molecular and Functional Diversity of Ant Venoms. ACS Pharmacology and Translational Science, 3(6), 1211–1224. https://doi.org/10.1021/acsptsci.0c00119

Braga Emidio, N., Brierley, S. M., Schroeder, C. I., & Muttenthaler, M. (2020). Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract. ACS Pharmacology and Translational Science, 3(4), 583-597. https://doi.org/10.1021/acsptsci.0c00023

Liu, H., Gruber, C. W., Alewood, P. F., Moller, A., & Muttenthaler, M. (2020). The oxytocin receptor signalling system and breast cancer: a critical review. Oncogene: including Oncogene Reviews, 39, 5917-5932. https://doi.org/10.1038/s41388-020-01415-8

Braga Emidio, N., Baik, H., Lee, D., Stuermer, R., Heuer, J., Elliott, A. G., Blaskovich, M. A. T., Haupenthal, K., Tegtmeyer, N., Hoffmann, W., Schroeder, C. I., & Muttenthaler, M. (2020). Chemical synthesis of human trefoil factor 1 (TFF1) and its homodimer provides novel insights into their mechanisms of action (vol 75, pg 5602, 2020). Chemical Communications, 56(51), 7049-7049. https://doi.org/10.1039/d0cc90250k

Emidio, N. B., Baik, H., Lee, D., Stuermer, R., Heuer, J., Elliott, A. G., Blaskovich, M. A. T., Haupenthal, K., Tegtmeyer, N., Hoffmann, W., Schroeder, C., & Muttenthaler, M. (2020). Chemical synthesis of human trefoil factor 1 (TFF1) and its homodimer provides novel insights into their mechanisms of action. Chemical Communications, 56(47), 6420-6423. https://doi.org/10.1039/d0cc02321c

Heuer, J., Heuer, F., Stuermer, R., Harder, S., Schlueter, H., Emidio, N. B., Muttenthaler, M., Jechorek, D., Meyer, F., & Hoffmann, W. (2020). The Tumor Suppressor TFF1 Occurs in Different Forms and Interacts with Multiple Partners in the Human Gastric Mucus Barrier: Indications for Diverse Protective Functions. International Journal of Molecular Sciences, 21(7), [2508]. https://doi.org/10.3390/ijms21072508